Medical Device ETFs Destined To Shine (IHI, PBE, MDT, COV, TMO, ILMN, SIAL)

Share This Article
January 13, 2011 11:20pm NYSE:IHI NYSE:PBE

Increased demand from emerging markets and domestic macro factors are expected to be major driving forces behind growth in the medical device and biotechnology sectors and the exchange

 traded funds (ETFs) that track them.

Emerging markets are expected to be at the forefront of economic growth for the next few years as many are rich in natural resources, which are expected to be in high demand in the near future, and most are much more nimble than their developed counterparties which enable them to grow at a more rapid pace.  Furthermore, many emerging nations were able to shun themselves from the global financial crisis due to lack of exposure to global credit markets and the natural propensity to save that is instilled in their consumers.

As a result of the expected growth in emerging markets, consumer wealth and purchasing power in these nations is expected to rise.   This should further result in increased demand for health-care services, which will likely result in upgrades to health-care infrastructure and enhancements to the desire to prolong life spans.

Further demand in the medical device sector is expected to dwell from macro changes in the United States, states Morgan Joseph of Barrons.   Some of these macro forces include a more restrictive Food and Drug Administration (FDA), increased reimbursement pressure, sluggish growth for elective services and continued pushback from health-care providers. 

At the end of the day, demand in the medical device sector is expected to increase in the near term future paving the path to opportunity for the following ETFs:

  • iShares Dow Jones US Medical Devices (NYSE:IHI), which boasts holdings such as Medtronic Inc. (NYSE:MDT), Covidien, Ltd. (NYSE:COV) and Thermo Fisher Scientific (NYSE:TMO).
  • PowerShares Dynamic Biotechnology & Genome Portfolio (NYSE:PBE), which boasts holdings such as Illumina Inc. (NASDAQ:ILMN) and Sigma-Aldrich Corporation (NASDAQ:SIAL).

Written By Kevin Grewal From ETF Tutor  Disclosure: No Positions 

Kevin Grewal is the founder, editor and publisher of ETF Tutor and serves as the editor at, where he focuses on mitigating risk and implementing exit strategies to preserve equity. Additionally, he is the editor at The ETF Institute, which is the only independent organization providing financial professionals with certification, education, and training pertaining to exchange-traded funds (ETFs). Prior to this, Grewal was a quantitative analyst at a small hedge fund where he constructed portfolios dealing with stock lending, exchange-traded funds, arbitrage mechanisms and alternative investments. He is an expert at dealing with ETFs and holds a bachelor’s degree from the University of California along with a MBA from the California State University, Fullerton. He is a contributing author on The Street – his articles can also be found published on various sites including Yahoo! Finance, The Globe and Mail , Daily Markets, MSN Money, Seeking Alpha, Fidelity Investments, Traders Library, and Minyanville.

Read Next

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories